MARON: Lonza, which is one of the 5 biomedical providers that collects them, issued a report recently and said which they have been genuinely concerned about long term supply. They felt that demand from customers for gene therapies and personalised medicine were being putting elevated stress on the species. Watson https://alfredp404bqf8.blogadvize.com/profile